Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneLinx is an early-stage healthcare technology company providing virtual access to board-certified genetic counselors. The service covers oncology risk assessment, reproductive carrier screening, proactive health management for common inherited conditions, and interpretation of direct-to-consumer test results. The company operates via both direct-to-consumer appointments as well as B2B partnerships with clinics/labs/employers. No drugs or therapeutics are developed by this entity—its focus is on education, navigation of testing options, interpretation of results, and empowering informed decision-making around personal/family genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneLinx.